CCO Expert Recap

Myelodysplastic Syndromes

Source: American Society of Hematology 2007 Annual Meeting*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Myelodysplastic Syndromes

CME Program Director:
Roy A. Beveridge, MD

Faculty:
Alan F. List, MD

CME CREDIT INFORMATION

Release Date: 02/21/08

Expiration Date: 02/20/09

Physicians: maximum of 0.75 AMA PRA Category 1 Credit(s)™

Registered Nurses: 0.9 Nursing CE credit

Status: Please log in to view status

Watch and listen as Alan F. List, MD reviews the latest treatment data on myelodysplastic syndromes from the 2007 Annual Meeting of the American Society of Hematology in Atlanta, Georgia.

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe the results of recent studies of the use of methyltransferase inhibitors in myelodysplastic syndromes
Discuss the development of new agents for use in the management of patients with myelodysplastic syndromes
Summarize new developments in the analysis of cytogenetic characteristics and the treatment of myelodysplastic syndromes
Relate outcomes of the analysis of supportive care in treatment of patients with myelodysplastic syndromes

Slideset